Literature DB >> 26666464

Characteristic Distribution Pattern of Lysophosphatidylcholine in Fibromuscular Dysplasia-Associated Visceral Artery Aneurysms Compared with Atherosclerotic Visceral Artery Aneurysms.

Hiroki Tanaka1, Nobuhiro Zaima, Takeshi Sasaki, Naoto Yamamoto, Kazunori Inuzuka, Masaki Sano, Hiroyuki Konno, Tetsumei Urano, Mitsutoshi Setou, Naoki Unno.   

Abstract

AIM: Asymptomatic visceral artery aneurysms (VAAs) have increasingly been found, with most being either atherosclerotic VAAs or fibromuscular dysplasia (FMD)-associated VAAs. However, little is known about the pathogenesis of both diseases. We aimed to identify the differences in the distribution pattern of lipid molecules between atherosclerotic VAAs and FMD-associated VAAs.
METHODS: We conducted a histological study of VAAs using imaging mass spectrometry (IMS) to assess the accumulation of lipid molecules in both the aneurysmal sac and the adjacent arteries without aneurysmal changes in 17 VAA samples, which were resected during the surgery.
RESULTS: IMS revealed characteristic distributions of cholesterol ester in intima and media in the atherosclerotic VAAs, which was hardly detected in FMD-associated VAAs. However, lysophosphatidylcholine (lysoPC), a proinflammatory and proapoptotic lipid mediator, was accumulated in the medial ridge of the adventitia of FMD-associated in the aneurysmal sac, and it was also diffusely accumulated in the adjacent arteries. In contrast, lysoPC was accumulated in the area of intimal hyperplasia in atherosclerotic VAAs and the adjacent arteries.
CONCLUSION: The distribution patterns of lipid molecules were different between the FMD-associated and atherosclerotic VAAs. The diffuse accumulation of lysoPCs in the visceral arteries may be a predisposition for the formation of FMD-associated VAAs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26666464      PMCID: PMC7399278          DOI: 10.5551/jat.32318

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  15 in total

1.  Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions.

Authors:  Nobuhiro Zaima; Takeshi Sasaki; Hiroki Tanaka; Xian Wu Cheng; Kenji Onoue; Takahiro Hayasaka; Naoko Goto-Inoue; Hirofumi Enomoto; Naoki Unno; Masafumi Kuzuya; Mitsutoshi Setou
Journal:  Atherosclerosis       Date:  2011-04-09       Impact factor: 5.162

2.  Ruptured visceral artery aneurysms.

Authors:  W H Wagner; A D Allins; R L Treiman; J L Cohen; R F Foran; P M Levin; D V Cossman
Journal:  Ann Vasc Surg       Date:  1997-07       Impact factor: 1.466

Review 3.  Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Authors:  Andrew Zalewski; Colin Macphee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

4.  Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL.

Authors:  C C Hsieh; M H Yen; H W Liu; Y T Lau
Journal:  Atherosclerosis       Date:  2000-08       Impact factor: 5.162

5.  Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.

Authors:  Isabel Gonçalves; Andreas Edsfeldt; Na Young Ko; Helena Grufman; Katarina Berg; Harry Björkbacka; Mihaela Nitulescu; Ana Persson; Marie Nilsson; Cornelia Prehn; Jerzy Adamski; Jan Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-12       Impact factor: 8.311

6.  Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix.

Authors:  I Gay; Z Schwartz; V L Sylvia; B D Boyan
Journal:  Biochim Biophys Acta       Date:  2004-08-30

7.  Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.

Authors:  H F McMurray; S Parthasarathy; D Steinberg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 8.  Common and Rare Variant Association Study for Plasma Lipids and Coronary Artery Disease.

Authors:  Hayato Tada; Masa-aki Kawashiri; Tetsuo Konno; Masakazu Yamagishi; Kenshi Hayashi
Journal:  J Atheroscler Thromb       Date:  2015-09-03       Impact factor: 4.928

Review 9.  Splanchnic artery aneurysms.

Authors:  Shabana F Pasha; Peter Gloviczki; Anthony W Stanson; Patrick S Kamath
Journal:  Mayo Clin Proc       Date:  2007-04       Impact factor: 7.616

Review 10.  Recent developments in the understanding and management of fibromuscular dysplasia.

Authors:  Sarah C O'Connor; Heather L Gornik
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

View more
  2 in total

1.  Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Authors:  Eikan Mishima; Shu Umezawa; Takehiro Suzuki; Miki Fujimura; Michiaki Abe; Junichiro Hashimoto; Takaaki Abe; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

2.  Comparative Metabolomics Analysis of Cervicitis in Human Patients and a Phenol Mucilage-Induced Rat Model Using Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Xiaoyong Zhang; Junmao Li; Bin Xie; Bei Wu; Shuangxia Lei; Yun Yao; Mingzhen He; Hui Ouyang; Yulin Feng; Wen Xu; Shilin Yang
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.